These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2474777)

  • 1. Biogenic amines and their metabolites in Alzheimer's disease: noradrenaline, 5-hydroxytryptamine and 5-hydroxyindole-3-acetic acid depleted in hippocampus but not in substantia innominata.
    Baker GB; Reynolds GP
    Neurosci Lett; 1989 May; 100(1-3):335-9. PubMed ID: 2474777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes of biogenic amines and their metabolites in postmortem brains from patients with Alzheimer-type dementia.
    Arai H; Kosaka K; Iizuka R
    J Neurochem; 1984 Aug; 43(2):388-93. PubMed ID: 6204013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine metabolism in senile dementia of Alzheimer type.
    Cross AJ; Crow TJ; Johnson JA; Joseph MH; Perry EK; Perry RH; Blessed G; Tomlinson BE
    J Neurol Sci; 1983; 60(3):383-92. PubMed ID: 6195313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A post-mortem study of noradrenergic, serotonergic and GABAergic neurons in Alzheimer's disease.
    Reinikainen KJ; Paljärvi L; Huuskonen M; Soininen H; Laakso M; Riekkinen PJ
    J Neurol Sci; 1988 Mar; 84(1):101-16. PubMed ID: 2452858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine neurotransmitters and their metabolites in brain regions in Alzheimer's disease: a postmortem study.
    Nazarali AJ; Reynolds GP
    Cell Mol Neurobiol; 1992 Dec; 12(6):581-7. PubMed ID: 1283363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct correlation between level of morphine and its biochemical effect on monoamine systems in mouse brain. Evidence for involvement of dopaminergic neurons in the pharmacological action of acute morphine.
    Ishikawa K; Shibanoki S; McGaugh JL
    Biochem Pharmacol; 1983 May; 32(9):1473-8. PubMed ID: 6190484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biogenic amines and their metabolites in brain tumor tissue].
    Kmieciak-Kołada K; Majchrzak H; Herman Z; Wencel T
    Neurol Neurochir Pol; 1984; 18(5):441-4. PubMed ID: 6084819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D-L-tetrahydropalmatine as monoamine depletor.
    Liu GQ; Algeri S; Garattini S
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):39-50. PubMed ID: 6182845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turnover of monoamines in hippocampus of rats fed on vitamin E-deficient diet.
    Castaño A; Vizuete ML; Cano J; Machado A
    Brain Res; 1993 Feb; 604(1-2):154-9. PubMed ID: 7681343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidepressant-like effect of flavonoids extracted from Apocynum venetum leaves on brain monoamine levels and dopaminergic system.
    Zheng M; Fan Y; Shi D; Liu C
    J Ethnopharmacol; 2013 May; 147(1):108-13. PubMed ID: 23453939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ventricular cerebrospinal fluid monoamine transmitter and metabolite concentrations reflect human brain neurochemistry in autopsy cases.
    Wester P; Bergström U; Eriksson A; Gezelius C; Hardy J; Winblad B
    J Neurochem; 1990 Apr; 54(4):1148-56. PubMed ID: 1968956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of quipazine and LSD on monoamines in the rat striatum.
    Miśkiewicz M; Rokosz-Pelc A; Vetulani J
    Pol J Pharmacol Pharm; 1979; 31(5):489-92. PubMed ID: 94944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective lesions by manganese and extensive damage by iron after injection into rat striatum or hippocampus.
    Sloot WN; van der Sluijs-Gelling AJ; Gramsbergen JB
    J Neurochem; 1994 Jan; 62(1):205-16. PubMed ID: 7505311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic system and monoamine oxidase-B activity in Alzheimer's disease.
    Reinikainen KJ; Paljärvi L; Halonen T; Malminen O; Kosma VM; Laakso M; Riekkinen PJ
    Neurobiol Aging; 1988; 9(3):245-52. PubMed ID: 3398991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain Serotonergic and Noradrenergic Deficiencies in Behavioral Variant Frontotemporal Dementia Compared to Early-Onset Alzheimer's Disease.
    Vermeiren Y; Janssens J; Aerts T; Martin JJ; Sieben A; Van Dam D; De Deyn PP
    J Alzheimers Dis; 2016 Jun; 53(3):1079-96. PubMed ID: 27314528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of barbitone sodium and thiopental sodium on brain dopamine, noradrenaline, serotonin and 5-hydroxyindoleacetic acid content in Arvicanthis niloticus.
    Fathi MM; Taha HM; Fahim el-S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 86(1):185-90. PubMed ID: 2435454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropathologic and neurochemical correlates of psychosis in primary dementia.
    Zubenko GS; Moossy J; Martinez AJ; Rao G; Claassen D; Rosen J; Kopp U
    Arch Neurol; 1991 Jun; 48(6):619-24. PubMed ID: 1710105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age-related changes on monoamine turnover in hippocampus of rats.
    Venero JL; de la Roza C; Machado A; Cano J
    Brain Res; 1993 Dec; 631(1):89-96. PubMed ID: 7507792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between the levels of biogenic amines and superoxide anion production in brain regions of rats after subchronic exposure to TCDD.
    Byers JP; Masters K; Sarver JG; Hassoun EA
    Toxicology; 2006 Dec; 228(2-3):291-8. PubMed ID: 17070641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.